Atlas Trials

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Clinical trial NCT01264822 · COMPLETED

Trial details

NCT number
NCT01264822
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
Start date
2011-01-13
Primary completion
2016-02-29
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.